Bernstein Maintains Outperform on Insulet, Lowers Price Target to $175
Insulet Corporation
Insulet Corporation PODD | 0.00 |
Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:
PODD) with a Outperform and lowers the price target from $200 to $175.
